LicianPro

DEXCOM INC ·

DXCM 8-K 2026-09-14

DEXCOM INC (DXCM) 8-K dated 2026-09-14 — accession 0001093557-26-000175.

DEXCOM INC (DXCM) is a medical devices company listed on US.

DEXCOM INC filed a 8-K on 2026-09-14. Accession 0001093557-26-000175.

This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported DXCM revenue for 2025-12-31 was $4.66B. Net income was $836.3M. Revenue was up 15.6% from 2024-12-31 to 2025-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 31.2.

Not investment advice. The DXCM SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr